What Researchers Did
Researchers looked back at medical records to compare surgery outcomes in patients who had radiation therapy and then breast reconstruction using their own tissue, with some patients receiving hyperbaric oxygen therapy (HBOT) and others not.
What They Found
This retrospective study of 14 patients found complication patterns that were similar between the two groups rather than showing a clear advantage for HBOT. Seven patients received HBOT and seven did not. In the non-HBOT group there was 1 Clavien-Dindo grade II complication, 1 grade IIIa, and 2 grade IIIb complications. In the HBOT group there were 3 grade I complications, 1 grade IIIa, and 2 grade IIIb complications. Average operative time for unilateral cases was about 452 minutes without HBOT and about 458 minutes with HBOT, a difference the abstract does not describe as meaningful.
What This Means for Canadian Patients
This study does not show that HBOT reduced complications after radiation and breast reconstruction surgery; both groups had similar rates of moderate to severe complications (grade IIIa and IIIb). The authors describe their findings as preliminary insight into HBOT's potential role in preparing irradiated tissue for this type of reconstruction, not as evidence that it improves outcomes. Canadian patients considering this surgery after radiation should discuss the current, limited state of this evidence with their surgical team.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This was a small, preliminary retrospective study of only 14 patients split into two groups of seven, which is too few to draw firm conclusions about whether HBOT changes complication risk after irradiated breast reconstruction.